Clinical utility of cell-free DNA based PTEN copy number loss in prostate cancer.

被引：0
|
作者：
Dong, Xiaoxi [1 ]
Zhang, Minghua [2 ]
Zheng, Tiantian [1 ]
Tan, Lu [1 ]
Xie, Feng [3 ]
Wang, Amy Xiaohong [1 ]
Du, Pan [1 ]
Jia, Shidong [1 ]
Lu, Chris [2 ]
Yu, Jianjun [1 ]
机构：
[1] Predicine, Hayward, CA USA
[2] Laekna Therapeut Shanghai Co, Shanghai, Peoples R China
[3] Huidu Shanghai Med Sci Ltd, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quantifying copy number variations in cell-free DNA for potential clinical utility from a large prostate cancer cohort
    Schuetz, Ekkehard
    Akbari, Mohammad R.
    Beck, Julia
    Urnovitz, Howard B.
    Zhang, William
    Mitchell, William M.
    Nam, Robert
    Narod, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
    Dong, Xiaoxi
    Zheng, Tiantian
    Zhang, Minhua
    Dai, Chao
    Wang, Lili
    Wang, Lei
    Zhang, Ruipeng
    Long, Yuan
    Wen, Danyi
    Xie, Feng
    Zhang, Yue
    Huang, Yong
    Dong, Jianguo
    Liu, Huan
    Du, Pan
    King, Bonnie L.
    Tan, Winston
    Jia, Shidong
    Lu, Chris X.
    Kohli, Manish
    Wang, Haitao
    Yu, Jianjun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Circulating cell-free DNA and its clinical utility in cancer
    Salviano-Silva, Amanda
    Maire, Cecile L.
    Lamszus, Katrin
    Ricklefs, Franz L.
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (04) : 265 - 272
  • [4] Cell-free DNA as a biomarker for taxane treatment in advanced prostate cancer.
    Sumanasuriya, Semini
    Seed, George
    Mehra, Niven
    Christova, Rossitza
    Pope, Lorna
    Goodall, Jane
    Flohr, Penelope
    Fowler, Gemma
    Bianchini, Diletta
    Rescigno, Pasquale
    Carreira, Suzanne
    Yuan, Wei
    Mace, Sandrine
    Chadjaa, Mustapha
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Plasma cell-free DNA-based prognosis in metastatic hormone sensitive prostate cancer.
    Kohli, Manish
    Yadav, Siddhartha
    Tan, Winston
    Bin Riaz, Irbaz
    Zheng, Tiantian
    Wang, Amy
    Montesinos, Carlos
    Wong, Calvin
    Du, Peter
    Jia, Shidong
    Yu, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [6] Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
    Chan, Ren-Hao
    Lin, Peng-Chan
    Chen, Shang-Hung
    Lin, Shao-Chieh
    Chen, Po-Chuan
    Lin, Bo-Wen
    Shen, Meng-Ru
    Yeh, Yu-Min
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Clinical utility of plasma cell-free DNA in patients with pancreatic cancer
    Chen, I.
    Wind, K. L.
    Dehlendorff, C.
    Sorensen, B. S.
    Vittrup, B. V.
    Johansen, A.
    Pfeiffer, P.
    Bjerregaard, J. K.
    Bojesen, S. E.
    Nielsen, S. E.
    Hollander, N. H.
    Yilmaz, M. K.
    Rasmussen, L. S.
    Pallisgaard, N.
    Johansen, J. S.
    Spindler, K-L. G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Cell-free DNA copy number variations in plasma from colorectal cancer patients
    Li, Jian
    Dittmar, Rachel L.
    Xia, Shu
    Zhang, Huijuan
    Du, Meijun
    Huang, Chiang-Ching
    Druliner, Brooke R.
    Boardman, Lisa
    Wang, Liang
    MOLECULAR ONCOLOGY, 2017, 11 (08): : 1099 - 1111
  • [9] Clinical utility of circulating cell-free DNA in advanced colorectal cancer
    Pereira, Allan A. Lima
    Morelli, Maria Pia
    Overman, Michael
    Kee, Bryan
    Fogelman, David
    Vilar, Eduardo
    Shureiqi, Imad
    Raghav, Kanwal
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Banks, Kimberly
    Lanman, Richard
    Talasaz, AmirAli
    Kopetz, Scott
    Van Morris
    PLOS ONE, 2017, 12 (08):
  • [10] Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer.
    Papadopoulou, E.
    Davilas, E.
    Sotiriou, V
    Koliopanos, A.
    Aggelakis, F.
    Dardoufas, K.
    Agnanti, N.
    Karydas, I
    Nasioulas, G.
    TUMOR BIOLOGY, 2006, 27 : 44 - 44
12345